Clinical Trial

Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients

Recruiting Phase 3

Record status

This record was last updated December 13, 2024 (before its estimated January 27, 2025 completion). Its status may not reflect the trial's current state.

Summary

Supraventricular tachycardia (SVT) is a term widely used to describe tachycardial dysrhythmias, paroxysmal SVT (PSVT) is a narrow term including only AV nodal re-entrant tachycardia (AVNRT) and atrioventricular re-entrant tachycardia (AVRT), both of which can cause discomfort and, in some cases, life-threatening symptoms. Usually Carotid sinus massage is done to lower the pulse rate and after the standard time specific verapamil dose is administered. In this study after carotid sinus massage Conventional Valsalva or modified Valsalva maneuver will be randomly applied. In case, the normal sinus rhythm (NSR) is not achieved then verapamil of or adenosine dose will be administered to the patients after after taking the consent.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-12-03.

Trial Details

NCT Number	NCT06717685
Lead Sponsor	Rashid Latif Medical College Collaborators: Punjab Institute of Cardology, Himmel Pharmaceutical private limited, Pakistan
Conditions	Supraventricular Tachycardia (SVtach)
Enrollment	210 participants
Start Date	2024-10-28
Primary Completion	2025-01-27 (estimated)
Study Completion	2025-02-03 (estimated)
Updated on ClinicalTrials.gov	2024-12-13